Sign up for free insights newsletter
Medicover AB (publ)

Medicover AB (publ)

MCOV-BNasdaq Stockholm

Need professional-grade analysis? Visit stockanalysis.com

SEK 189.00
-3.96%
End of day
Market Cap

$30.11B

P/E Ratio

35.86

Employees

49,000

Dividend Yield

0.10%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.01-3.08-2.04-2.58-0.39-1.77
Calmar-21.07-6.00-3.12-1.72-0.21-3.36
Sharpe-2.18-3.12-1.44-1.90-0.24-1.44
Omega0.000.290.700.630.980.67
Martin-36.40-14.26-7.77-3.07-0.46-6.85
Ulcer2.465.515.7415.8515.5311.45

Medicover AB (publ) (MCOV-B) Price Performance

Medicover AB (publ) (MCOV-B) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at SEK189.00, down 3.96% from the previous close.

Over the past year, MCOV-B has traded between a low of SEK184.30 and a high of SEK285.50. The stock has lost 7.2% over this period. It is currently 33.8% below its 52-week high.

Medicover AB (publ) has a market capitalization of $30.11B, with a price-to-earnings ratio of 35.86 and a dividend yield of 0.10%.

About Medicover AB (publ)

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Company Info

Exchange
Nasdaq Stockholm
Currency
SEK
Country
Sweden

Financial Metrics

Revenue (TTM)
$2.38B
EBITDA
$276.70M
Profit Margin
3.26%
EPS (TTM)
5.56
Book Value
3.53

Technical Indicators

52 Week High
SEK 295.00
52 Week Low
SEK 182.11
50 Day MA
SEK 209.85
200 Day MA
SEK 240.64
Beta
1.59

Valuation

Trailing P/E
35.86
Forward P/E
64.94
Price/Sales
12.66
Price/Book
5.43
Enterprise Value
$45.12B